LYTIR

Company · AQST

Aquestive Therapeutics, Inc.

Nasdaq's symbol directory lists AQST on Nasdaq as “Aquestive Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($99K); insiders sold on 9 occasions ($734K); 3 planned-sale notices; 2 filings by holders of 5% or more; 9 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $99K in total; Insider sales: $734K in total.Jun: Insider sales $229KJul: Insider sales $100KAug: Insider sales $107KSep: Insider sales $166KOct: Insider sales $106KNov: Insider purchases $99KNov: Insider sales $26KDecJanFebMarAprMayJunJulAugSepOctNov$99K$229K
Insider purchases above the line: $99KInsider sales below: $734K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Barber Daniel, President and CEO sold on 6 days all under a 10b5-1 plan latest Oct 15, 2026 sold $537K
  2. Krop Julie sold on 1 day all under a 10b5-1 plan latest Jun 23, 2026 sold $125K
  3. Daly Richard J bought on 1 day latest Nov 10, 2026 bought $99K
  4. Korczynski Sherry, Chief Commercial Officer sold on 1 day all under a 10b5-1 plan latest Sep 9, 2026 sold $46K
  5. Davis Matthew W., Chief Development Officer sold on 1 day all under a 10b5-1 plan latest Nov 12, 2026 sold $26K
Every trade (10)
  1. SELLDavis Matthew W., Chief Development Officer sold Nov 12, 2026 7,197 shares 10b5-1 plan (scheduled) filing $26K
  2. BUYDaly Richard J bought Nov 10, 2026 28,025 shares 2 legs combined filing $99K
  3. SELLBarber Daniel, President and CEO sold Oct 15, 2026 25,000 shares 10b5-1 plan (scheduled) filing $106K
  4. SELLBarber Daniel, President and CEO sold Sep 15, 2026 25,000 shares 10b5-1 plan (scheduled) filing $120K
  5. SELLKorczynski Sherry, Chief Commercial Officer sold Sep 9, 2026 8,750 shares 10b5-1 plan (scheduled) filing $46K
  6. SELLBarber Daniel, President and CEO sold Aug 17, 2026 25,000 shares 10b5-1 plan (scheduled) filing $107K
  7. SELLBarber Daniel, President and CEO sold Jul 16, 2026 20,369 shares 10b5-1 plan (scheduled) filing $82K
  8. SELLBarber Daniel, President and CEO sold Jul 15, 2026 4,631 shares 10b5-1 plan (scheduled) filing $19K
  9. SELLKrop Julie sold Jun 23, 2026 25,000 shares 10b5-1 plan (scheduled) filing $125K
  10. SELLBarber Daniel, President and CEO sold Jun 15, 2026 25,000 shares 10b5-1 plan (scheduled) filing $104K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. MATTHEW W DAVIS filed Nov 12, 2026 Officer 7,197 shares planned sale date 11/12/2026 filing $26K
  2. Daniel Barber filed Sep 15, 2026 Director 50,000 shares planned sale date 09/15/2026 filing $244K
  3. Sherry M. Korczynski filed Sep 9, 2026 Officer 8,750 shares planned sale date 09/09/2026 filing $46K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Bass Edward P filed Oct 7, 2026 Schedule 13G passive filing 7.5%
  2. BRATTON DOUGLAS K filed Oct 7, 2026 Schedule 13G/A passive filing 0.6%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 16, 2026
  2. Regulation FD disclosure filing Nov 5, 2026
  3. Results of operations and financial condition; Regulation FD disclosure filing Nov 3, 2026
  4. Amendments to articles or bylaws; change in fiscal year filing Oct 19, 2026
  5. Regulation FD disclosure filing Oct 15, 2026
  6. Entry into a material definitive agreement filing Oct 14, 2026
  7. Departure or appointment of directors or officers filing Sep 29, 2026
  8. Regulation FD disclosure filing Sep 25, 2026
  9. Regulation FD disclosure; Other events filing Sep 17, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.